10X Genomics Inc (NASDAQ:TXG)
| 144.48 Delayed Data As of 4:00pm ET |  -4.44 / -2.98%Today’s Change | 128.15 Today|||52-Week Range 208.99 | +2.03% Year-to-Date |
Latest TXG News | Press Releases
| 10x Genomics Stock: Bull vs. Bear Nov 24 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 148.92 |
| Today’s open | 149.09 |
| Day’s range | 140.38 - 149.09 |
| Volume | 95,301 |
| Average volume (3 months) | 597,270 |
| Market cap | $16.6B |
Data as of 4:00pm ET, 11/29/2021
Growth & Valuation
| Earnings growth (last year) | -1,552.45% |
| Earnings growth (this year) | +91.35% |
| Earnings growth (next 5 years) | -109.13% |
| Revenue growth (last year) | +21.53% |
| P/E ratio | NM |
| Price/Sales | 47.93 |
| Price/Book | 21.80 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 22, 2022 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $298.8M |
| Annual profit (last year) | -$542.7M |
| Net profit margin | -181.61% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
